Abstract
Aim of the present study was to assess the prevalence of atrial fibrillation (AF) in patients with two different types of cancer. Recent epidemiologic and clinical studies support the hypothesis that AF is promoted and maintained by a broad spectrum of modulating factors. A total of 2,339 patients admitted to the Surgery Department of “Luigi Sacco Hospital, Milan,” over the period 1987–2004 were eligible for the study. One thousand three hundred and seventeen patients were admitted consecutively with a first diagnosis of colorectal or breast cancer (cases). The remaining 1,022 were patients admitted to undergo non-neoplastic surgery (controls). Routine pre-surgery electrocardiogram available in patient charts was analysed by a cardiologist who was not aware of the present study to evaluate the presence of atrial fibrillation or other arrhythmias. Overall, AF was present in 3.6% cases and 1.6% controls. This corresponded to at least two times higher likelihood of having AF in cases compared to controls. Prevalence of AF increased with age both in cases and controls. Our study describes an increased prevalence of AF in two different types of cancer. Autonomic, endocrine, coagulation, and inflammatory alterations were previously described in both AF and cancer, and can provide the physiopathological basis to our clinical observation.
Similar content being viewed by others
References
Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB (1998) Impact of atrial fibrillation on the risk of death. Framingham Heart Study Circulation 98:946–952
Patel PJ, Keating RJ, Gersh BJ, Hodge DO, Hammill SC, Shen WK (2004) Outcome of patients with newly diagnosed atrial fibrillation at the Mayo Clinic and residing in that area. Am J Cardiol 94:1379–1382
Tsang TSM, Gersh BJ (2002) Atrial fibrillation: an old disease, a new epidemic. Am J Med 113:432–435
Anderson JL, Allen Maycock CA, Lappe DL (2004) Intermountain heart collaborative study group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 94:1255–1259
Kolb C, Nurnberger S, Ndrepepa G, Zrenner B, Schomig A, Schmitt C (2001) Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system. Am J Cardiol 88:853–857
Rugo HS (2004) Paraneoplastic syndromes and other non-neoplastic effects of cancer. In: Goldman L, Ausiello D (eds) Cecil textbook of medicine, 22nd edn. Saunders, Philadelphia, pp 1124–1131
Chung MK, Martin DO, Sprecher D (2001) C-reactive protein elevation in patients with atrial arrhythmias. Circulation 104:2886–2891
Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA (2003) Inflammation as a risk factor for atrial fibrillation. Circulation 108:3006–3010
Muller AD, Sonnenberg A, Wasserman IR (1994) Diseases preceding colon cancer. A case-control study among veterans. Dig Dis Sci 39:2480–2484
Brathwaite D, Weissman C (1998) The new onset of atrial arrhythmias following major noncardiothoracic surgery is associated with increased mortality. Chest 1144:62–68
Siu CW, Tung HM, Chu KW, Jim MH, Lau CP, Tse HF (2005) Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer. PACE 22:S120–S123
Aziz SA, Tramboo NA, Mohi-ud-Din K, Iqbal K, Jalal S, Ashmad M (1998) Supraventricular arrhythmia: a complication of 5-fluorouracil therapy. Clin Oncol UK 10:377–378
Guzzetti S, Costantino G, Sada S, Fundarò C (2002) Colorectal cancer and atrial fibrillation: a case-control study. Am J Med 112:587–588
Levy S (1997) Factors predisposing to the development of atrial fibrillation. PACE 10(2):2670–2674
Wyse DG, Gersh BJ (2004) Atrial fibrillation: a perspective. Circulation 109:3089–3095
Wigmore SJ, Maingay JP, Fearon KC, O’Riordain MG, Ross JA (1998) Effect of interleukin-4 on pro-inflammatory cytokine production and the acute phase response in healthy individuals and in patients with cancer or multiple organ failure. Clin Sci 95:347–354
Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incidental colorectal cancer. JAMA 291:585–590
O’Hanlon DM, Lynch J, Cormican M, Given HF (2002) The acute phase response in breast carcinoma. Anticancer Res 22:1289–1293
Walsh SR, Gladwish KM, Ward NJ, Justin TA, Keeling NJ (2004) Atrial fibrillation and survival in colorectal cancer. World J Surg Oncol 2:40–45
Martin R, Delgado JM, Molto JM, Vincent JM, Manzanares R, Insa R (1992) Cardiovascular reflexes in patients with malignant disease. Ital J Neurol Sci 13:125–129
Sørensen HT, Mellemkjær L, Steffensen FH, Olsen JH, Nielsen GL (1998) The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338:1169–1173
Skelton CL (1982) The heart and hyperthyroidism. N Engl J Med 307:1206–1208
Anhalt GJ, Kim SC, Stanley JR 1990 Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729–1735
Darnell RB (1996) Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci 93:4529–4536
Kim YI, Neher E (1988) IgG from patients with Lambert–Eaton syndrome blocks voltage-dependent calcium channels. Science 239:405–408
Vernino S, Adamski J, Krjzer TJ, Fealey RD, Lennon WA (1998) Neuronal nicotinic Ach-receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50:1806–1813
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guzzetti, S., Costantino, G., Vernocchi, A. et al. First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation. Intern Emerg Med 3, 227–231 (2008). https://doi.org/10.1007/s11739-008-0124-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-008-0124-4